Pilot to Assess Feasibility of Using RecoverLINK Technology to Supplement Outpatient Care for Heart Failure Patients
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 46
- 试验地点
- 1
- 主要终点
- User engagement: # symptom surveys completed/30 days
研究概览
简要总结
The primary objective is to examine feasibility of incorporating RecoverLINK into the standard of care as a function of (i) user engagement, (ii) user satisfaction, and (iii) workflow efficiency. As secondary objectives, the investigators will collect preliminary data to examine the association between patient engagement with the RecoverLINK app and (i) changes in patient knowledge and behavior, and (ii) hospital readmission(s) at 30, 60, and 90-day time periods post-enrollment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Heart failure (HF) patients with a rapid follow up appointment scheduled at the Mount Sinai HF clinic
- •English-speaking
- •With either access to (i) an iOS smart device or (ii) wifi at-home
排除标准
- •Patients meeting any of the following criteria:
- •A heart transplant
- •A mechanical circulatory support (MCS) device
- •An altered mental status
- •Serious co-morbidities (as identified by Mount Sinai team)
- •Cognitive impairments (as identified by Mount Sinai team)
- •Inability to use technology (as identified by Mount Sinai team)
研究组 & 干预措施
RecoverLINK technology
RecoverLINK is a two-part mHealth technology designed to supplement traditional care transitional programs for heart failure (HF) patients.
干预措施: RecoverLINK technology (Other)
结局指标
主要结局
User engagement: # symptom surveys completed/30 days
时间窗: 30 days
User satisfaction: Percent patients report "satisfied" via post-program survey
时间窗: 30 days
Workflow efficiency: mean/median time to resolution of patient alerts
时间窗: 30 days
次要结局
- Hospital admission(30, 60, 90 days)
- Mean difference in pre/post SCHIFI score(30 days)